MeSH tree: D03.132.436.613
Psychedelics, psychoactive substances that alter people's perceptions, mood and thought patterns, have recently shown promise for the treatment of some mental health disorders, including depression and substance use disorders ...
Psilocybin—the psychedelic compound that occurs naturally in certain "magic" mushroom species—has been shown in trials to provide long-term treatment for depression and anxiety. But the chemical's hallucinogenic effects can ...
Jan 13, 2026
0
101
In a review of previous studies, McMaster University researchers observe a stronger signal for psilocybin as a treatment for obsessive-compulsive disorder than cannabinoids.
A new UBC Okanagan study found that people who microdose psychedelics feel better on the days they take them—but those boosts don't seem to last.
Dec 11, 2025
0
20
Psilocybin is a psychedelic drug with promising clinical applications for treating mood disorders and substance abuse disorders. Recent work in functional MRI (fMRI) studies show that psychedelics can reset brain network ...
Dec 9, 2025
0
55
Debate over psychedelic legalization tends to focus on two extreme views: the need to speed therapeutic access to meet urgent problems such as veteran suicide, and calls to thoroughly research substances first to ensure they ...
Dec 8, 2025
0
15
An international collaboration led by Cornell researchers used a combination of psilocybin and the rabies virus to map how—and where—the psychedelic compound rewires the connections in the brain.
Dec 6, 2025
0
119
People who have received emergency or hospital care in Canada due to hallucinogen use have a six-fold increased risk of receiving care for mania in the next three years, according to a study published in PLOS Medicine by ...
Dec 2, 2025
0
21
As interest in psychedelics surges across the United States, a new study led by researchers at the University of Michigan and the University at Buffalo offers critical harm-reduction guidance for individuals considering their ...
Dec 2, 2025
0
24
Researchers from the University of Liège and international collaborators developed a "virtual clinical trial" exploring a unique pharmacological treatment in patients who do not fully regain consciousness after a coma. The ...
Nov 24, 2025
0
50
